Upgrade to SI Premium - Free Trial

Medtronic, Inc. (MDT) PT Raised to $93 at Oppenheimer Following 4Q

May 26, 2017 9:52 AM
Oppenheimer raised its price target on Medtronic, Inc. (NYSE: MDT) to $93.00 (from $87.00) while maintaining a Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles